These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Effects of high grade antiretroviral therapy on body fat distribution and metabolism]. Schwenk A Zentralbl Gynakol; 1999; 121(11):552-3. PubMed ID: 10612226 [No Abstract] [Full Text] [Related]
16. Overcoming obstacles to the success of protease inhibitors in highly active antiretroviral therapy regimens. Moyle G AIDS Patient Care STDS; 2002 Dec; 16(12):585-97. PubMed ID: 12542932 [TBL] [Abstract][Full Text] [Related]
17. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. Calza L; Manfredi R; Chiodo F J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323 [TBL] [Abstract][Full Text] [Related]
18. Substitution for protease inhibitors in HIV therapy. Mikhail E N Engl J Med; 2003 Dec; 349(25):2460-1; author reply 2460-1. PubMed ID: 14689602 [No Abstract] [Full Text] [Related]
19. Antiretroviral treatment for HIV infection/AIDS and the risk of developing hyperglycemia and hyperlipidemia. de Araújo PS; de Alencar Ximenes RA; Lopes CF; Duarte JY; da Silva MM; Carneiro EM Rev Inst Med Trop Sao Paulo; 2007; 49(2):73-8. PubMed ID: 17505662 [TBL] [Abstract][Full Text] [Related]
20. Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy. Bard JM; Lassalle R; Capeau J; Bach-Ngohou K; Nazih-Sanderson F; Rémy G; Reynes J; Ecobichon JL; Savès M; Raffi F; Antivir Ther; 2006; 11(3):361-70. PubMed ID: 16759053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]